Skip to main content
David A. Ginsberg

David A. Ginsberg

🇺🇸 United States🏥 USC Keck School of MedicineMD
▶ Videos (1)

Training and career​

  • Current position Professor of clinical urology, Keck School of Medicine of USC; chief of urology, Rancho Los Amigos National Rehabilitation Center1
  • Medical school Keck School of Medicine of USC1
  • Residency Urology, Keck School of Medicine of USC and affiliated Los Angeles County Medical Center1
  • Fellowship Female urology, voiding dysfunction, and urologic reconstruction, UCLA1

Key Publications​

His cited work includes the AUA/SUFU guideline papers on diagnosis, evaluation, treatment, and follow-up of adult neurogenic lower urinary tract dysfunction, a trial of onabotulinumtoxinA for neurogenic detrusor overactivity, and a long-term study of urologic care after spinal cord injury. Other cited work addresses urinary diversion and bladder neck closure.P2P3P1P4P5

  1. Ginsberg D, Gousse A, Keppenne V, et al. "Phase 3 Efficacy and Tolerability Study of OnabotulinumtoxinA for Urinary Incontinence From Neurogenic Detrusor Overactivity." Journal of Urology. 2012;187(6):2131–2139. doi

    Phase 3 onabotulinumtoxinA trial for neurogenic detrusor overactivity (2012). Ginsberg led a phase 3 trial of intradetrusor onabotulinumtoxinA for urinary incontinence caused by neurogenic detrusor overactivity.

    Cited on: Intradetrusor OnabotulinumtoxinA · Botulinum Toxin (Neuromodulation Adjunct) · Botulinum Toxin (OnabotulinumtoxinA & Variants)
  2. Ginsberg DA, Boone TB, Cameron AP, et al. "The AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction: Treatment and Follow-up." Journal of Urology. 2021;206(5):1106–1113. doi

    AUA/SUFU adult neurogenic lower urinary tract dysfunction guideline (2021). Ginsberg chaired the AUA/SUFU guideline panel addressing evaluation, risk stratification, treatment and follow-up of adults with neurogenic lower urinary tract dysfunction.

    Cited on: Principles of Bladder Augmentation · Botulinum Toxin (Neuromodulation Adjunct) · Gabapentinoids
  3. Ginsberg DA, Boone TB, Cameron AP, et al. The AUA/SUFU guideline on adult neurogenic lower urinary tract dysfunction: diagnosis and evaluation. J Urol. 2021;206:1097–1105. doi
    Cited on: Intermittent Catheters and Clean Intermittent Catheterization (CIC) · Suprapubic Catheter (SPT) · Endoscopy — Cystoscopy & Ureteroscopy
  4. Stein JP, Lieskovsky G, Ginsberg DA, Bochner BH, Skinner DG. "The T Pouch: An Orthotopic Ileal Neobladder Incorporating a Serosal Lined Ileal Antireflux Technique." J Urol. 1998;159(6):1836–42. doi
    Cited on: Double T-Pouch · Kock Pouch · T-Pouch Orthotopic Ileal Neobladder
  5. Ginsberg DA. The argument for ileal conduit for the poorly compliant bladder in the neurogenic lower urinary tract dysfunction patient refractory to minimally invasive treatment. Neurourol Urodyn. 2026.
    Cited on: Augmentation Cystoplasty · Ileovesicostomy

Other Publications Cited on WARWIKI

9 additional publications with David A. Ginsberg as a listed author are cited on WARWIKI, ordered by the number of pages that cite them. Papers whose author list is shortened to "et al." before this name are not included.

  1. Nitti VW, Ginsberg D, Sievert KD, et al. "Durable efficacy and safety of long-term onabotulinumtoxinA treatment in patients with overactive bladder syndrome: final results of a 3.5-year study." J Urol. 2016;196(3):791–800. doi
    Cited on: Botulinum Toxin (Neuromodulation Adjunct) · Botulinum Toxin (OnabotulinumtoxinA & Variants) · Nitti OAB Trial: OnabotulinumtoxinA 100 U for Overactive Bladder with Urinary Incontinence
  2. Bochner BH, Stein JP, Ginsberg DA, et al. "A Serous Lined Antireflux Valve: In Vivo Fluorourodynamic Evaluation of Antireflux Continence Mechanism." J Urol. 1998;160(1):112–5. doi
    Cited on: Double T-Pouch · T-Pouch Orthotopic Ileal Neobladder
  3. Goldenberg MG, Ginsberg DA. Urethrovaginal Fistula. In: Sotelo R, Polotti CF, Arriaga J, eds. Urinary Fistula. Springer; 2022:161-174.
    Cited on: Urethrovaginal Fistula Repair
  4. Rosenberg S, Miranda G, Ginsberg DA. "Neobladder–vaginal fistula: The University of Southern California experience." Neurourol Urodyn. 2018;37(4):1380–1385. doi
    Cited on: Hautmann W-Configuration Ileal Neobladder
  5. Gao Y, Danforth T, Ginsberg DA. "Urologic Management and Complications in Spinal Cord Injury Patients: A 40- to 50-year Follow-up Study." Urology. 2017;104:52-58. doi
    Cited on: Spinal Cord Injury
  6. Ginsberg DA. Transvaginal Bladder Neck Closure. In: Goldman HB, ed. Complications of Female Incontinence and Pelvic Reconstructive Surgery. 2nd ed. Springer (Humana Press); 2017:239-244. doi
    Cited on: Bladder Neck Closure
  7. Shpall AI, Ginsberg DA. Bladder neck closure with lower urinary tract reconstruction: technique and long-term followup. J Urol. 2004;172(6 Pt 1):2296-9. doi
    Cited on: Bladder Neck Closure
  8. Stein JP, Grossfeld GD, Freeman JA, Esrig D, Ginsberg DA, Cote RJ, et al. "Orthotopic Lower Urinary Tract Reconstruction in Women Using the Kock Ileal Neobladder: Updated Experience in 34 Patients." J Urol. 1997;158(2):400-405. doi
    Cited on: Kock Pouch
  9. Ginsberg D, Huffman JL, Lieskovsky G, Boyd S, Skinner DG. "Urinary Tract Stones: A Complication of the Kock Pouch Continent Urinary Diversion." J Urol. 1991;145(5):956–9. doi
    Cited on: Kock Pouch

Footnotes​

  1. David Ginsberg. USC Profiles. Accessed October 2026. ↩ ↩2 ↩3 ↩4